Evidence map›Paper›PMID 31647372›Full record

ArticlePersonalized medicine2019

Genetic variants of nucleotide excision repair pathway and outcomes of induction therapy in acute myeloid leukemia.

Zohreh Sharifi, Mohammad Faranoush, Alireza Mohseni, Shahrbano Rostami, Mani Ramzi, Mohammad J Sharifi

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Personalized medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 82% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Zohreh SharifiBlood Transfusion Research Center, High Institute for Research & Education in Transfusion Medicine, Tehran, Iran.
Mohammad FaranoushRasool Akram Complex Medical Center, Iran University ofMedical Sciences, Tehran, Iran.
Alireza MohseniThalassemia Research Center, Hemoglobinopthy Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Shahrbano RostamiHaematology-Oncology & Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran,Iran.
Mani RamziHematology Research Center, Shiraz University of Medical Sciences, Shiraz, Fars, Iran.
Mohammad J SharifiBlood Transfusion Research Center, High Institute for Research & Education in Transfusion Medicine, Tehran, Iran.
High Institute for Education and Research in Transfusion Medicine · IRIran University of Medical Sciences · IRMazandaran University of Medical Sciences · IRShiraz University of Medical Sciences · IRTehran University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAdultAgedCase-Control StudiesDNA-Binding ProteinsDNA Excision Repair Protein ERCC-5DNA RepairEndonucleasesFemaleGenetic Predisposition to DiseaseGenotypeHumansInduction ChemotherapyLeukemia, Myeloid, AcuteMaleMiddle AgedDNA-Binding ProteinsDNA Excision Repair Protein ERCC-5EndonucleasesERCC1 protein, humanERCC2 protein, humanNuclear ProteinsTranscription FactorsXeroderma Pigmentosum Group D ProteinXPC protein, humanAMLcomplete remissioninduction therapyNERtoxicityXPD

Identifiers

PMID31647372
PMCPMC7677594
OpenAlexW2982167116

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.